Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05598853
What this trial is testing

Intrathecal Double Checkpoint Inhibition

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung Cancer Stage IVMelanoma Stage IV
University of Zurich 26
Testing effectiveness (Phase 2)WithdrawnNCT00916669
What this trial is testing

Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT00323869
What this trial is testing

Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer (NSCLC)
Stanford University 48
Not applicableLooking for participantsNCT07708870
What this trial is testing

Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerAdvanced Lung CancerCaregiver Burden+1 more
National Taiwan University Hospital 120
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Not applicableLooking for participantsNCT06481813
What this trial is testing

Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients

Who this might be right for
Lung CancerCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma+1 more
Nantes University Hospital 730
Large-scale testing (Phase 3)Study completedNCT02438722
What this trial is testing

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
SWOG Cancer Research Network 174
Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Testing effectiveness (Phase 2)Ended earlyNCT05191797
What this trial is testing

Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell Carcinoma
University of Washington 3
Large-scale testing (Phase 3)Active Not RecruitingNCT02306161
What this trial is testing

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Bone Marrow+3 more
National Cancer Institute (NCI) 312
Testing effectiveness (Phase 2)Looking for participantsNCT06788912
What this trial is testing

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Who this might be right for
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06698042
What this trial is testing

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 67
Testing effectiveness (Phase 2)Looking for participantsNCT06125041
What this trial is testing

Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Who this might be right for
Extensive Small Cell Lung Cancer
Qianfoshan Hospital 51
Not applicableActive Not RecruitingNCT05853887
What this trial is testing

Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

Who this might be right for
Non Small Cell Lung Cancer MetastaticNewly Diagnosed NSCLCNon-Squamous Non-Small Cell Neoplasm of Lung
Charu Aggarwal 260
Not applicableUnknownNCT02613637
What this trial is testing

Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

Who this might be right for
Lung Cancer
University of Ulm 2,000
Large-scale testing (Phase 3)Ended earlyNCT03745222
What this trial is testing

Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 1
Not applicableStudy completedNCT01081496
What this trial is testing

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT00334815
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Large Cell Carcinoma+4 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Ended earlyNCT01357655
What this trial is testing

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Who this might be right for
Leukemia
Bristol-Myers Squibb 70
Next Page